These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 18024389

  • 1. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.
    Buchler T, Bomanji J, Lee SM.
    Haematologica; 2007 Nov; 92(11):e120-1. PubMed ID: 18024389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
    Lee SM, Buchler T, Bomanji J, Ramsay A, Edwards SG.
    AIDS; 2008 Jan 02; 22(1):159-60. PubMed ID: 18090408
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M.
    Clin Cancer Res; 2006 Nov 01; 12(21):6487-93. PubMed ID: 17085663
    [Abstract] [Full Text] [Related]

  • 7. ABVD chemotherapy of Hodgkin's disease.
    Molnár Z, Schneider T, Várady E, Fleischmann T.
    Neoplasma; 1997 Nov 01; 44(4):263-5. PubMed ID: 9473781
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE, National Cancer Institute of Canada Clinical Trials Group, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jul 20; 23(21):4634-42. PubMed ID: 15837968
    [Abstract] [Full Text] [Related]

  • 9. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G, Bonfante V, Viviani S, Di Russo A, Villani F, Valagussa P.
    J Clin Oncol; 2004 Jul 15; 22(14):2835-41. PubMed ID: 15199092
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C, Gallamini A, Stracqualursi L, Agati P, Tripodo C, Fuligni F, Sista MT, Fanti S, Biggi A, Vitolo U, Rigacci L, Merli F, Patti C, Romano A, Levis A, Trentin L, Stelitano C, Borra A, Piccaluga PP, Hamilton-Dutoit S, Kamper P, Zaucha JM, Małkowski B, Kulikowski W, Tajer J, Subocz E, Rybka J, Steidl C, Broccoli A, Argnani L, Gascoyne RD, d'Amore F, Zinzani PL, Pileri SA.
    Lancet Haematol; 2016 Oct 15; 3(10):e467-e479. PubMed ID: 27692305
    [Abstract] [Full Text] [Related]

  • 12. [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY.
    Ai Zheng; 2006 Apr 15; 25(4):471-5. PubMed ID: 16613683
    [Abstract] [Full Text] [Related]

  • 13. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
    Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Wit M, Paulus U, Hasenclever D, Loeffler M, Müller RP, Müller-Hermelink HK, Dühmke E, Diehl V.
    J Clin Oncol; 2007 Aug 10; 25(23):3495-502. PubMed ID: 17606976
    [Abstract] [Full Text] [Related]

  • 14. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
    Canellos GP, Duggan D, Johnson J, Niedzwiecki D.
    J Clin Oncol; 2004 Apr 15; 22(8):1532-3. PubMed ID: 15084636
    [No Abstract] [Full Text] [Related]

  • 15. Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease.
    Amadori S, Papa G, Anselmo AP, Fidani P, Mandelli F, Biagini C.
    Cancer Treat Rep; 1983 Jun 15; 67(6):603-4. PubMed ID: 6190561
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly.
    Stamatoullas A, Brice P, Bouabdallah R, Mareschal S, Camus V, Rahal I, Franchi P, Lanic H, Tilly H.
    Br J Haematol; 2015 Jul 15; 170(2):179-84. PubMed ID: 25891777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.